Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphiros has launched commercial consumer diagnostic products such as the GoToKnow™ COVID‑19 Antigen Rapid Test and NowFuture™ genomic wellness tests. Its advanced therapy/cell therapy programs are preclinical but have shown promising results in tissue regeneration models. The company continues to expand its portfolio into at-home blood collection devices and multiplexed molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphiros.